Associate Professorchairman of a research committee
Hayato Hikita
Hayato Hikita
Specialties
Chronic hepatitis (viral liver disease, fatty liver disease, autoimmune hepatobiliary disease, etc.)
Acute hepatitis (including fulminant hepatitis, etc.)
hepatobiliary pancreatic cancer
Career History
- Jun 2001 Resident, Osaka University Hospital
- Jun 2002 Resident and intern at National Osaka Minami Hospital (now Osaka Minami Medical Center)
- Apr 2006 Osaka University Hospital, Medical Staff
- Apr 2007 Doctoral Program in Clinical Medicine, Department of Internal Medicine, Osaka University Graduate School of Medicine
- Mar. 2010 Completed the same (early completion at the end of the third year)
- Apr 2012 Project Assistant Professor, Department of Gastroenterology, Osaka University Graduate School of Medicine
- Apr 2015 Assistant Professor, Department of Gastroenterology, Osaka University Graduate School of Medicine
- Apr 2017 Lecturer, Department of Gastroenterology, Osaka University Graduate School of Medicine
- Aug 2022 Lecturer, Department of Gastroenterology, Osaka University Graduate School of Medicine
- Mar 2026 Associate Professor, Department of Gastroenterology, Osaka University Graduate School of Medicine
Board Certification, Specialist Certification, Instructor, Councilor, etc.
- Japanese Society of Internal Medicine: Councilor, Kinki Branch Councilor, Specialist in General Internal Medicine, Medical Advisor
- Japanese Society of Gastroenterology: Councilor of the Society, Councilor of Kinki Branch Meeting, Specialist, Medical Advisor
- Japan Society of Hepatology: Councilor of the Society, Councilor of the Western Society, Medical Specialist, Medical Advisor
- Japanese Society of Gastrointestinal Endoscopy: Councilor of Kinki Branch, Medical Specialist, Medical Advisor
- The Japanese Cancer Association: Councilor
- Japan Organization of Medical Examiners for Cancer Therapy: Board Certified Cancer Therapy Physician
- American Association for the Study of Liver Diseases: Fellow (FAASLD)
Hobbies
Reading, golf, domestic and international travel
Message
We are conducting research to clarify how hepatobiliary and pancreatic diseases occur and progress at the molecular level, and to develop new treatment methods and indicators (biomarkers) for diagnosis and prediction based on these findings.
As a medical scientist, my motto is to sincerely deal with patients and science.